These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17323831)

  • 1. Vitamin D3-24-hydroxylase (CYP24) as a potential target for intervention with diabetic and nondiabetic nephropathy.
    Weiher H; Zwacka RM
    Clin Lab; 2007; 53(1-2):85-8. PubMed ID: 17323831
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice.
    Xiao X; Ma B; Dong B; Zhao P; Tai N; Chen L; Wong FS; Wen L
    J Autoimmun; 2009 Mar; 32(2):85-93. PubMed ID: 19200691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Astragalus mongholicus on renal gene expression profile in mice with diabetic nephropathy].
    Hong XP; Zhang XZ; He XL; Huang XZ; Chen HR; Wang YZ
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):676-80. PubMed ID: 18590199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
    Daniel C; Schaub K; Amann K; Lawler J; Hugo C
    Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of growth arrest-specific gene 6 in diabetic nephropathy.
    Arai H; Nagai K; Doi T
    Vitam Horm; 2008; 78():375-92. PubMed ID: 18374201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy.
    Hamada Y; Miyata S; Nii-Kono T; Kitazawa R; Kitazawa S; Higo S; Fukunaga M; Ueyama S; Nakamura H; Yodoi J; Fukagawa M; Kasuga M
    Nephrol Dial Transplant; 2007 Jun; 22(6):1547-57. PubMed ID: 17360766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats.
    Li Y; Qi Y; Kim MS; Xu KZ; Huang TH; Rong X; Murray M; Yamahara J
    Diabetes Metab Res Rev; 2008 Sep; 24(6):498-506. PubMed ID: 18613221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy.
    Park JK; Ronkina N; Höft A; Prohl C; Menne J; Gaestel M; Haller H; Meier M
    Nephrol Dial Transplant; 2008 Jun; 23(6):1844-53. PubMed ID: 18182404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of type III and type IV collagen in diabetic nephropathy.
    Razzaque MS; Taguchi T
    Diabetologia; 1995 May; 38(5):632-3. PubMed ID: 7489852
    [No Abstract]   [Full Text] [Related]  

  • 10. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
    Hamada Y; Fukagawa M
    Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal metabolism and actions of histamine and serotonin.
    Abboud HE; Dousa TP
    Miner Electrolyte Metab; 1983; 9(4-6):246-59. PubMed ID: 6318063
    [No Abstract]   [Full Text] [Related]  

  • 12. [The genetic aspects of the development of diabetic nephropathy (a review of the literature)].
    Dedov II; Shestakova MV; Mozgovaia ME
    Ter Arkh; 1993; 65(10):9-13. PubMed ID: 8296246
    [No Abstract]   [Full Text] [Related]  

  • 13. Decrease of bone morphogenetic protein-7 (BMP-7) and its type II receptor (BMP-RII) in kidney of type 1-like diabetic rats.
    Yeh CH; Chang CK; Cheng MF; Lin HJ; Cheng JT
    Horm Metab Res; 2009 Aug; 41(8):605-11. PubMed ID: 19440953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kidney expression of matrix metalloproteinase-9 in the diabetic nephropathy of Kkay mice.
    Qing-Hua G; Ju-Ming L; Chang-Yu P; Zhao-Hui L; Xiao-Man Z; Yi-Ming M
    J Diabetes Complications; 2008; 22(6):408-12. PubMed ID: 18413157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
    Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of myo-inositol oxygenase is involved in the tubulointerstitial injury of diabetic nephropathy.
    Lu Y; Liu C; Miao X; Xu K; Wu X; Liu C
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):257-65. PubMed ID: 19053028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
    Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth pattern switch of renal cells and expression of cell cycle related proteins at the early stage of diabetic nephropathy.
    Zhang Y; Shi Y; Liu Y; Dong H; Liu M; Li Y; Duan H
    Biochem Biophys Res Commun; 2007 Nov; 363(1):159-64. PubMed ID: 17825795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of compound Rhizoma Coptidis capsule on expression of transforming growth factor-beta1 and type IV collagen proteins in renal tissue of diabetic rats with nephropathy].
    Liu S; Tang LQ; Chen LM; Chen XQ; Zhang ST; Wei Y
    Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):68-72. PubMed ID: 18338624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of glomerular SREBP-1c in diabetic nephropathy.
    Ishigaki N; Yamamoto T; Shimizu Y; Kobayashi K; Yatoh S; Sone H; Takahashi A; Suzuki H; Yamagata K; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2007 Dec; 364(3):502-8. PubMed ID: 17961514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.